Data / Form D filings / GreenMark Biomedical Inc.
GreenMark Biomedical Inc.: Form D filings
GreenMark Biomedical Inc., a biotechnology company in East Lansing, MI, filed 6 Form D notices with the SEC between 2018 and 2026. The latest, on April 14, 2026, reports an offering of $5 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 325 E. GRAND RIVER AVENUE SUITE 314, East Lansing, MI, 48823
- Phone
- (517) 896-3665
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1741718
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Jan 21, 2025 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| Oct 31, 2022 | New notice | $1,000,000 | $500,000 | $500,000 | 3 | Oct 14, 2022 | sec.gov |
| Jul 17, 2020 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Mar 19, 2019 | Amendment | $1,200,000 | $1,200,000 | 0 | May 11, 2018 | sec.gov | |
| May 24, 2018 | New notice | $1,080,000 | $185,000 | $895,000 | 0 | May 11, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Bloembergen PhD | Executive Officer, Director | |
| Joerg Lahann, PhD | Director | |
| Michael Snyder | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Apr 13, 2026 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GreenMark Biomedical Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.